Status:
COMPLETED
Rapid Antimicrobial Susceptibility Testing with MIC Directly from Positive Blood Cultures with ASTar
Lead Sponsor:
University Hospital, Ghent
Conditions:
Bacteremia
Eligibility:
All Genders
Phase:
NA
Brief Summary
The investigators want to investigate the clinical impact of early antimicrobial susceptibility results for gram negative bacilli isolated from blood cultures on antimicrobial choices and early switch...
Detailed Description
Sepsis and septic shock are defined as a (life-threatening) organ dysfunction caused by an (uncontrolled) host response to an infection. Sepsis remains a leading cause of morbidity and mortality world...
Eligibility Criteria
Inclusion
- Patients with blood culture positive with gram negative bacilli
- \-
Exclusion
- Mixed blood culture positivity on Gram stain
- Positive blood culture with gram negative bacilli in the previous 7 days
- Life expectancy of \< 48 hours
Key Trial Info
Start Date :
January 10 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06218277
Start Date
January 10 2024
End Date
August 31 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghent University Hospital
Ghent, Belgium, 9000